Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole

被引:60
作者
Ashton, WT
Sisco, RM
Hong, D
Lyons, KA
He, HB
Doss, GA
Leiting, B
Patel, RA
Wu, JK
Marsilio, F
Thornberry, NA
Weber, AE
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Preclin Drug Metab, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
关键词
D O I
10.1016/j.bmcl.2005.03.012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of beta-aminoacylpiperidines bearing various fused five-membered heterocyclic rings was synthesized as dipeptidyl peptidase IV inhibitors. Potent and relatively selective inhibition could be obtained, depending on choice of heterocycle, regioisomerism, and substitution. In particular, one analog (74, DPP-IV IC50 = 26 nM) exhibited good oral bioavailability and acceptable half-life in the rat, albeit with rather high clearance. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2253 / 2258
页数:6
相关论文
共 33 条
  • [1] GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
    Ahrén, B
    Schmitz, O
    [J]. HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 867 - 876
  • [2] Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes
    Augustyns, K
    Van der Veken, P
    Senten, K
    Haemers, A
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (04) : 499 - 510
  • [3] Barlocco Daniela, 2004, Curr Opin Investig Drugs, V5, P1094
  • [4] The multifunctional or moonlighting protein CD26/DPPIV
    Boonacker, E
    Van Noorden, CJF
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 2003, 82 (02) : 53 - 73
  • [5] Design and asymmetric synthesis of beta-strand peptidomimetics
    Boumendjel, A
    Roberts, JC
    Hu, E
    Pallai, PV
    Rebek, J
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (13) : 4434 - 4438
  • [6] CALDWELL CD, UNPUB
  • [7] Chen T, 2004, J BIOL REG HOMEOS AG, V18, P47
  • [8] Chen T, 2003, ADV EXP MED BIOL, V524, P79
  • [9] Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes
    D'Alessio, DA
    Vahl, TP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (06): : E882 - E890
  • [10] Inhibitors of dipeptidyl peptidase IV:: a novel approach for the prevention and treatment of Type 2 diabetes?
    Deacon, CF
    Ahrén, B
    Holst, JJ
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) : 1091 - 1102